Navigation Links
Regulus Announces Significant Progress in Strategic Alliance with AstraZeneca and Selection of a New Pre-Clinically Validated microRNA Oncology Target
Date:10/28/2013

LA JOLLA, Calif., Oct. 28, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of an undisclosed oncology target by AstraZeneca under the strategic alliance to discover, develop, and commercialize microRNA therapeutics.  Regulus and AstraZeneca continue to collaborate on three exclusive microRNA targets in cardiovascular and metabolic diseases and oncology.

"We are very pleased with the successful relationship we have built with AstraZeneca and their selection of a validated microRNA target for oncology indications," said Neil W. Gibson, Ph.D., Chief Scientific Officer of Regulus.  "In the last year, we have made significant progress in advancing our drug discovery efforts against the portfolio of AstraZeneca targets.  With the support of AstraZeneca's drug development expertise and commitment to the RNA therapeutics field, we continue to harness our microRNA expertise to develop innovative, first-in-class treatment options for patients in need." 

In August 2012, Regulus and AstraZeneca formed a strategic alliance focused on three exclusive microRNA targets for cardiovascular and metabolic diseases and oncology, which includes Regulus' program targeting microRNA-33 for the treatment of atherosclerosis.  Under the terms of the alliance, Regulus will lead preclinical development and, if successful, could receive preclinical milestone payments.  AstraZeneca will lead and fund the clinical development and commercialization of these programs.  In addition, Regulus could also receive clinical milestones based on the successful development of microRNA therapies in each target area. Regulus is also eligible to receive significant launch
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights
2. Regulus Announces Timing for Second Quarter 2013 Financial Results Webcast and Conference Call
3. Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors
4. Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference
5. Regulus Provides Update on Road to the Clinic Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
6. Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
7. Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors
8. Regulus to Present at Future Leaders in the Biotech Industry Conference
9. Regulus to Present at Cowen and Company 33rd Annual Healthcare Conference
10. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
11. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Former NASA scientist Tamim Hamid ... he discussed Theradome™, the first portable and wearable OTC ... shows firsthand how, via laser technology, Theradome™ offers individuals ... will not require surgery or medication.  ... of the hair follicle, which is where the stem ...
(Date:5/4/2015)... PAREXEL International Corporation (NASDAQ: PRXL ) announced ... Conference on Monday, May 18, 2015, in New York City.  ... Officer will be making a presentation on PAREXEL and discussing ... webcast of the presentation will be available through the "Investors" ... Upcoming Events portion of the main page, and a replay ...
(Date:5/4/2015)... May 4, 2015 Rogne Bioscience, a privately-held ... announced that preclinical and mechanism of action data will ... of Investigative Dermatology (SID) Annual Meeting being held May ... Atlanta, Georgia . Logo - http://photos.prnewswire.com/prnh/20150501/213318LOGO ... of RON2315, a novel, low MW (<1700 daltons) peptide ...
Breaking Medicine Technology:FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2PAREXEL International to Present at UBS Healthcare Conference 2Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2
(Date:5/4/2015)... TROY Healthcare Solutions is proud to be a sponsor ... Conference in Baltimore, MD from May 11 – 13, ... an opportunity for clients to gather to network, attend ... addition to sponsoring the event, TROY Healthcare Solutions will ... Attendees can stop by the TROY booth and see ...
(Date:5/4/2015)... American Telemedicine Association (ATA) today released an update to ... coverage and reimbursement, and physician practice standards and licensure. ... last September, many state regulating bodies responded by looking ... in their state,” said Jonathan Linkous, CEO of ATA. ... ATA reevaluated the indicators for each state and issued ...
(Date:5/4/2015)... Jacksonville, Fla. (PRWEB) May 04, 2015 ... American Heart Association/American Stroke Association’s Get With The ... the Target: Stroke Honor Roll. The award recognizes ... stroke patients receive the most appropriate treatment according ... latest scientific evidence. , To receive the Gold ...
(Date:5/4/2015)... 04, 2015 METTLER TOLEDO has ... of Data Integrity in a GXP Regulated Laboratory ... presenter. This webinar will be presented on May ... Data integrity is a critical component of pharmaceutical ... agencies. However, in recent years an increasing number ...
(Date:5/4/2015)... Now in its seventh year, the ... have made outstanding contributions to the company, to their ... acute and post-acute care settings. The five award categories ... the Year, Advanced Practice Clinician of the Year, Newcomer ... Year. Recipients are selected by IPC’s senior management team. ...
Breaking Medicine News(10 mins):Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3
... Provide General Information about Potential Health ConcernsNEWTON, Mass., May ... in the reinvention of how people obtain legal services, ... general information about the potential health hazards of excessive ... consumer product used by an estimated 35 million Americans ...
... Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) ... "first-in-human" application of the Aethlon Hemopurifier(R) to treat ... Acquired Immune Deficiency Syndrome (AIDS). Aethlon announced ... treatments during the span of one month, had ...
... (NYSE: APD ) today announced it has ... business and some elements of its respiratory and home ... of Walgreen Co. Terms of the agreement were ... certain of the companies previously operated as part of ...
... online resource, HealthInsuranceFinders.com, recently published a 2009 Guide ... free guide, users gain invaluable knowledge of available ... May 5 HealthInsuranceFinders.com, a popular online health ... a free 2009 Guide to Health ...
... Management WASHINGTON, May 5 ... announced today that Christine G. Leyden, Senior Vice President, ... for URAC has been recognized as a leader in ... magazine. Ms. Leyden will be featured in the publication,s ...
... TooNEW YORK, May 5 Honk if you,re thinking about Mom. ... to think of the perfect Mother,s Day gift, the National Kidney ... unique gift -- one that may save lives and save you ... this traditional time of love and giving to donate your used ...
Cached Medicine News:Health News:Sokolove Law Launches Denture Cream Consumer Hotline 2Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 2Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 3Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 4Health News:Aethlon Medical Discloses New HIV/AIDS Treatment Data 5Health News:Air Products Sells Major Portion of U.S. Healthcare Operations to Walgreens 2Health News:New 2009 Guide To Health Insurance for the Unemployed Available at HealthInsuranceFinders.com 2Health News:New 2009 Guide To Health Insurance for the Unemployed Available at HealthInsuranceFinders.com 3Health News:Case in Point Magazine Names URAC Senior Vice President Leader in Health Care Accreditation 2Health News:Case in Point Magazine Names URAC Senior Vice President Leader in Health Care Accreditation 3
Liquichek Pediatric Control is a product designed to monitor important analytes for neonatal testing. This control monitors four bilirubin parameters at two clinically significant levels....
... Chemistry Control (Human) provides a comprehensive ... enzymes and CO2. It requires no ... most major instruments and methodologies. Available ... fill sizes (10 mL fill size ...
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels....
Lyphochek® Drug Free Serum can serve as a drug-free baseline for HPLC analysis or as a negative control....
Medicine Products: